ARCHIVES

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

OPR Reinstates Duke Medical Center’s License To Conduct Human Studies

May 28, 1999

Varmus Pools $13.4 M. To Fund Projects; NCI Gives $2.6 Mil.

December 9, 1994

Senate “Pleased” About Reductions In Incidence And Mortality

October 8, 1999

Cancer Meetings Listed

April 18, 1997

NCI’s Future Depends On Recruiting Youth to Careers in Science, NCI Director Says at His Swearing-In Ceremony.

October 20, 2006

In Brief: Brian Henderson Names New Director Of USC Comprehensible Cancer Center, Norris Hospital

April 8, 1983